01 March 2017 by Cihangir Kaymaz

Clinical, laboratory , echocardiographic and hemodynamic characteristics in relation to survival in pulmonary arterial hypertension associated with congenital heart disease

Pulmonary arterial hypertension (PAH) associated with congenital heart disease (APAH-CHD) is classified as a subgroup of PAH that includes four different forms sharing a similar clinical and pathological findings. However, attention has been focused on the Eisenmenger syndrome (ES) and predictors of the survival in other patients (pts) with APAH-CHD remain to be determined.

In this study, we investigated clinical, biochemical, neurohumoral, echocardiographic and hemodynamic predictors of the survival in 134 pts with APAH-CHD (F72 M 62, age 40.7±17.5  years) out of the 341 pts  included into the our single-centre, prospective study. Subgroups of APAH-CHD were as follows: 1.ES (n=71) 2.PAH associated with prevalent systemic-to-pulmonary shunts (n=37), and 4. PAH after defect correction (n=26). Baseline six-minute walk distance (6MWD) was 301.5±127.8 m, and pulmonary arterial systolic and mean pressures (PASP, PAMP, mm Hg) were 99.6±32.9 and 64.7±22.85, and transpulmonary and diastolic pressure gradients (TPG,DPG,mm Hg) were 51.8±22.9 and 29.6±20.3, respectively. Pulmonary and systemic vascular resistance (PVR,SVR,WU) and PVR/SVR ratio were 10.6±9.3, 21.8±9.6 and 0.52±0.37, respectively. Targeted PAH treatments were noted in 100 (75%) pts. Mean follow-up was 30.9 ± 28 (0,5- 122,6) months. The APAH-CHD compared with idiopathic PAH(IPAH) and PAH-associated with connective tissue disease (APAH-CTD) was associated with a better 8-year survival (83 vs 54,4 and 61%, p<0,05), and APAH-CHD subgroups  showed comparable survival (p>0,05). The age, sex, functional class, haemoglobin, oxyhaemoglobin saturation %, C-reactive  protein, uric acid and brain natriuretic  peptide were not related with  survival(p>0,05). Neither tertile  definition (<190,190-330,>331), nor pre-defined cut-off values of 6MWD (m) (<165, 165-440,> 440)  related with APAH-CHD survival(p>0,05). Similarly, tertiles  of TPG,DPG, PVR and PVR/SVR  ratio  showed  comparable survival (p>0,05). However, pericardial  effusion(p=0,0001) and the  highest tertile of right atrial  pressure (RAP,mm Hg ) (> 11 vs 9-11 and < 9, p<0.01) were found  to  discriminate  the  high-risk pts.

In  conclusion, APAH-CHD compared with other PAH subgroups is associated with a better survival. However, only pericardial effusion and RAP predict the worst clinical outcome in these patients.

Key Contributors

C. Kaymaz1 , O. Akbal1, A. Hakgor1, F. Yilmaz1 ,C.E. Yıldız1, T. Aktemur1, S. Turkday1, HC. Tokgoz1, S.Tanyeri 1, Kartal Kosuyolu Heart Education and Research Hospital, Istanbul, Turkey

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI